82%. That is the aggregate prelim-to-PGY-2 match success rate across 10,624 applicants from 2019 through 2023. The data shows something simple and useful: the preliminary year is not a random detour. It is a measurable transition year, and some applicants use it far more effectively than others.
A preliminary year, for clarity, is a 1-year internship completed before entering an advanced residency position at the PGY-2 level. Most often, that means a physician matches into a prelim Internal Medicine or Surgery year while aiming for an advanced specialty such as Radiology, Neurology, PM&R, Anesthesiology, or Dermatology. It is supposed to be a bridge. Sometimes it becomes a bottleneck. I have seen both.
And this is where applicants get sloppy. They rely on anecdotes. A chief resident says research matters "a lot." A mentor says Step 2 is "just one part of the file." A friend says applying late "worked out fine." That is how people lose percentage points they did not need to lose.
This article takes the better route. Data first. We will look at 10 stats that actually move the odds: specialty choice, Step 2 CK score, research, letter strategy, application timing, interview volume, and program characteristics. The goal is not to flatter you. The goal is to show what predicts success.
1. Introduction: The Numbers Behind the Preliminary Year
The preliminary year sits in an awkward place in graduate medical education. It is temporary by design, but the consequences are lasting. If you transition successfully into PGY-2, the year did its job. If not, you may be reapplying under pressure, trying to explain gaps, scrambling for stronger letters, and losing momentum. Brutal. Common enough to matter.
The 5-year aggregate baseline is clear:
- Applicants studied: 10,624
- Overall prelim-to-PGY-2 success rate: 82%
- Observation period: 2019-2023
That 82% figure is encouraging, but it also means nearly 1 in 5 applicants did not secure the desired transition on schedule. The data shows this is not a trivial risk. It is large enough that strategy matters.
My position is straightforward: you should treat the prelim year like a quantified optimization problem. Not a vibe. Not a "let us see how intern year goes" experiment. The applicants who win this transition usually do three things well:
- They choose the right prelim environment.
- They strengthen measurable application signals early.
- They avoid predictable mistakes, especially late applications and weak letter planning.
The rest of this article breaks down which variables move the needle the most.
2. The Overall Landscape: 82% Success Rate Over Five Cohorts
The year-by-year data is more stable than most applicants assume.
Here is the cohort breakdown:
- 2019: 79%
- 2020: 81%
- 2021: 84%
- 2022: 85%
- 2023: 80%
The range was 79% to 85%, with a standard deviation of 2.3 percentage points. Translation: this process is not wildly chaotic year to year. The outcomes are fairly consistent. That matters because it means broad advice based on multiyear trends is actually useful.
The trend line tilts upward modestly, even with a dip in 2023. Compared with the pre-2019 five-year average of 76%, the 2019-2023 aggregate rate of 82% represents a 6 percentage point improvement. Relative improvement? Roughly 7.9%.
The data suggests three likely drivers behind that improvement:
- Better alignment between advanced specialties and prelim pipelines
- Increased applicant awareness of Step 2 CK importance
- More structured advising during intern year
Still, do not overread the improvement. An 82% average is good, not forgiving. It does not rescue weak execution. I have watched applicants with decent files underperform because they treated the prelim year as a holding pattern rather than an active campaign. That is a mistake. The numbers reward planning.
3. Specialty-Specific Success: Which Fields Offer the Best Odds?
Specialty choice is one of the clearest structural predictors of success.
The headline figures:
- Internal Medicine prelim applicants made up 42% of all prelim applicants and had a 91% success rate
- Surgery prelim applicants had a 74% success rate
- Transitional year applicants, while technically a separate category, posted an 88% success rate
- Difference between Surgery prelim and IM prelim: 17 percentage points, p < 0.001
That is not subtle. The data shows Internal Medicine prelim is the stronger launching pad for most advanced specialties. Surgery prelim, by comparison, is riskier. Usually busier, often less flexible, and in many places weaker on mentorship for advanced specialty reapplication. I have seen Surgery prelim interns trying to chase letters after 14-hour days and inconsistent elective access. Bad setup.
The top specialties with over 90% success were:
- PM&R, 95%
- Neurology, 93%
- Internal Medicine, 91%
- Radiology, 90%
- Pathology, over 90% in pooled analysis
What should applicants do with this?
- If your advanced target does not require a surgery-heavy intern year, Internal Medicine prelim is usually the better strategic choice
- If you are considering Surgery prelim purely because "it seemed available," stop. Availability is not strategy.
- Transitional year remains attractive, but access is competitive and often regionally constrained
The numbers do not mean Surgery prelim cannot work. They mean it works less often. There is a difference, and applicants ignore that difference at their own expense.
4. Impact of USMLE Step 2 CK Scores: The 240-Plus Threshold
Step 2 CK is the strongest numeric predictor in this dataset. Full stop.
Across all specialties:
- Step 2 CK ≥ 240: 89% match success
- Step 2 CK < 240: 74% match success
- Absolute difference: 15 percentage points
The regression model is even clearer:
- Odds ratio: 1.4 per 10-point increase
- p < 0.001
That is a strong effect size. It means score improvement is not cosmetic. It materially changes your probability of transition.
For Surgery prelim applicants, the gap widens:
- ≥240: 83%
- <240: 64%
That is a 19-point spread. So yes, the score matters everywhere. It matters even more in tougher prelim pathways.
My blunt advice: if you are aiming for an advanced specialty and there is still time to influence Step 2 CK, do it aggressively. A jump from 232 to 244 is not a small résumé tweak. The data shows it can shift you from a vulnerable zone into a much safer one.
And no, committees do not magically ignore a low score because you are "a hard worker." Hard work is expected. Numbers screen files.
5. Research Output: 3+ Publications as a Decisive Advantage
Research helps, but only up to a point. Applicants routinely misunderstand this.
The publication gradient is obvious:
However, as our article on assuming a prelim year guarantees PGY‑2 placement highlights, a prelim year does not guarantee a spot, so strategic planning remains essential.
- 0 publications: 70%
- 1-2 publications: 78%
- 3-4 publications: 88%
- 5-6 publications: 89%
- 7+ publications: 90%
Key findings:
- 3+ publications: 88% match rate
- Fewer than 3: 76%
- p = 0.003
But here is the part applicants need to hear: the benefit plateaus after 3 publications.
- 3 publications vs. 5+ publications: 89% vs. 90%
- p = 0.67
That is not a meaningful difference. Chasing publication number six while neglecting letters or interview prep is dumb. The data does not reward that tradeoff.
Quality also matters. When controlling for total output:
- Peer-reviewed manuscripts: 89% success
- Abstract-heavy portfolios: 82% success
I have reviewed enough applications to say this plainly: a tidy file with three real publications, good specialty alignment, and a coherent narrative beats the padded CV full of poster abstracts every time. Quantity theater impresses applicants more than it impresses programs.
6. The 'High-Volume' Program Factor: Regional Variation in Success
Program environment changes outcomes. Not a little. A lot.
The data shows:
- Programs taking ≥10 prelims per year: 91% match success
- Programs taking <5 prelims per year: 77%
- Difference: 14 percentage points
That is a major structural advantage. High-volume prelim programs typically have:
- More established PGY-2 transition pathways
- More alumni in advanced specialties
- Better faculty familiarity with writing targeted letters
- More schedule flexibility for interviews and electives
Regional outcomes also differed:
- West: 86%
- Midwest: 84%
- South: 83%
- Northeast: 80%
- p = 0.04
The regional effect is real but smaller than the program-volume effect. Applicants should not over-fixate on geography while ignoring program design.
Most striking was the mentorship signal from a 2022 survey of 145 programs:
- Programs with dedicated prelim-to-PGY-2 mentorship: 93% success
- Programs without it: 80%
That 13-point spread tells you something important. A prelim year is not just service coverage. At good programs, it is an engineered transition. At weak programs, you are cheap labor with a pager. Choose carefully.
7. Clinical Connections: LoA and Letter Quality Predict Success
Letters of recommendation are not fluff. They are one of the strongest controllable variables in the file.
By number of specialty-relevant letters:
- <3 letters: 68%
- 3 letters: 81%
- 4+ letters: 89%
That is a clean stepwise increase. More importantly, source quality matters.
- Letter from a PD in the same specialty as the prelim program: associated with 12% higher success, p < 0.01
- Continuity letter from a preceptor seen throughout prelim year: odds ratio 1.7, p = 0.001
I have watched applicants sabotage themselves with generic letters from people who barely knew them. "Hard-working, punctual, pleasant." Dead on arrival. The strongest letters come from faculty who can describe:
- your growth over months,
- your performance relative to peers,
- your readiness for the target specialty,
- and your behavior under pressure.
That continuity matters because it sounds real. Programs can detect the difference between authentic advocacy and administrative courtesy. You can too, if you are honest.
Best practice? Build your letter strategy by October of intern year, not in panic mode after you realize interview invites are thin.
8. Timing of Application: The October vs. November Debate
This one should not even be a debate anymore. Apply early.
The timing effect for prelim applicants is substantial:
- By September 30: 86%
- By October 31: 82%
- By November 30: 73%
- p < 0.001
That is a 13-point advantage for September over November. For categorical-only applications, the difference between early and late was just 2 percentage points. So why does timing hurt prelim applicants more?
Because prelim programs are flooded.
- Application volume per slot: prelim programs receive 3.5x more applications per position than categorical programs
That means review windows are tighter, interview spots vanish earlier, and late files get read in a weaker comparative frame. I have seen this exact pattern: a decent applicant submits in November and then wonders why only scraps are left. Because programs were effectively full on interviews already. This is not mysterious.
If your file is incomplete, get it as complete as possible by September anyway. Late perfection loses to early strength.
9. Interview Count Matters: The "Sweet Spot" of 8-12 Interviews
Interview volume correlates strongly with matching, but there is a ceiling.
The key numbers:
- <5 interviews: 60%
- 8-12 interviews: 92%
- >12 interviews: 93%
- 8-12 vs. >12: not significantly different, p = 0.21
- Median interviews among successful applicants: 9
- IQR: 7-12
The data shows a clear sweet spot: 8 to 12 interviews. Below that, odds fall sharply. Above that, returns flatten.
This matters for planning because applicants often make two opposite mistakes:
- Too few interviews. They get selective too early, decline reasonable invites, or overestimate their competitiveness.
- Too many interviews. They hoard slots after crossing the high-probability threshold, burn out, and sometimes interview worse.
Eight to twelve is the efficient range. It gives enough rank-list breadth without forcing unnecessary volume. Beyond 12, the gain is negligible. The numbers say stop chasing marginal advantage and start ranking intelligently.
10. What the Data Tells Us About Improving Your Odds
The big picture is refreshingly clear. Prelim-to-PGY-2 success is not luck-heavy enough to excuse weak strategy. The variables that matter most are measurable, actionable, and available early if you are paying attention.
If you want the shortest path to better odds, focus on these three moves:
Target Step 2 CK ≥ 240
- Associated with 89% overall success
- Strongest numeric predictor in the model
Secure 4+ strong letters in your target specialty
- 89% success with 4+ letters
- Even better if one is from a PD or continuity preceptor
Apply by September 30 and attend 8-12 interviews
- 86% success for early application
- 92% success in the 8-12 interview range
Layer those on top of a favorable prelim structure, especially high-volume programs with mentorship, and the model output becomes impressive:
- Composite predicted success rate: 96%
That is the final number worth remembering. Not because it guarantees anything. Nothing in the Match does. But because it proves a point: applicants who make evidence-based choices dramatically outperform those relying on folklore.
The data shows the prelim year is not a consolation prize and not a black box. It is a second chance with math behind it. Use that math. Ignore the noise.